PTE, a novel module to target Polycomb Repressive Complex 1 to the human cyclin D2 (CCND2) oncogeneVisa övriga samt affilieringar
2018 (Engelska)Ingår i: Journal of Biological Chemistry, ISSN 0021-9258, E-ISSN 1083-351X, Vol. 293, nr 37, s. 14342-14358Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
Polycomb group proteins are essential epigenetic repressors. They form multiple protein complexes of which two kinds, PRC1 and PRC2, are indispensable for repression. Although much is known about their biochemical properties, how mammalian PRC1 and PRC2 are targeted to specific genes is poorly understood. Here, we establish the cyclin D2 (CCND2) oncogene as a simple model to address this question. We provide the evidence that the targeting of PRC1 to CCND2 involves a dedicated PRC1-targeting element (PTE). The PTE appears to act in concert with an adjacent cytosine-phosphate-guanine (CpG) island to arrange for the robust binding of PRC1 and PRC2 to repressed CCND2. Our findings pave the way to identify sequence-specific DNA-binding proteins implicated in the targeting of mammalian PRC1 complexes and provide novel link between polycomb repression and cancer.
Ort, förlag, år, upplaga, sidor
American Society for Biochemistry and Molecular Biology, 2018. Vol. 293, nr 37, s. 14342-14358
Nyckelord [en]
polycomb, epigenetics, gene silencing, chromatin, oncogene, cyclin D2, polycomb targeting, PRC1
Nationell ämneskategori
Medicinsk genetik och genomik
Identifikatorer
URN: urn:nbn:se:umu:diva-152251DOI: 10.1074/jbc.RA118.005010ISI: 000444671500015PubMedID: 30068546Scopus ID: 2-s2.0-85053313839OAI: oai:DiVA.org:umu-152251DiVA, id: diva2:1253309
Forskningsfinansiär
Åke Wibergs StiftelseMagnus Bergvalls StiftelseCancerfondenVetenskapsrådetKnut och Alice Wallenbergs StiftelseKempestiftelserna2018-10-042018-10-042025-02-10Bibliografiskt granskad